A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
スポンサーリンク
概要
著者
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
Murate T
Nagoya University School Of Health Science
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
OGITA Masami
Sapporo National Hospital
-
Suzuki R
Department Of Hsct Data Management Nagoya University Hospital
-
Suzuki Ritsurou
東京大学医学部附属病院 無菌治療部
-
Suzuki Ritsuro
豊橋市民病院 血液･腫瘍内科
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Kobayashi Tohru
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Taniwaki M
Kyoto Prefectural Univ. Medicine Kyoto
-
Takatoku Masaaki
Department Of Hematology And Oncology Kyoto Prefectural University Of Medicine
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
KINOSHITA Tomohiro
First Department of Internal Medicine, Nagoya University School of Medicine
-
MIURA Kazuhisa
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
-
Nakamura S
Department Of Pathology And Clinical Laboratories Nagoya University Hospital
-
Nakamura Shigeo
Department Of Pathology Nagoya University School Of Medicine
-
Taji Hirohumi
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
TASHIRO Kazuhiro
Department of Pathology, Toyota Memorial Hospital
-
UEHIRA Kazutaka
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
-
TACHI Hiroshi
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
-
KUROKAWA Toshiro
First Department of Internal Medicine, Nagoya University School of Medicine
-
MURATE Takashi
First Department of Internal Medicine, Nagoya University School of Medicine
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Ogita Masami
Graduate School Of Electronic Science And Technology Shizuoka University
-
Miura Kazuhisa
Department Of Internal Medicine & Molecular Science Nagoya City University Graduate School Of Me
-
Suzuki Ritsurou
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Tsukasaki Kunihiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Tateno Masatoshi
Department Of Pathology Asahikawa Medical College
-
Kinoshita T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kinoshita Tomohiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Tagawa Hiroyuki
Department Of Mathematical Sciences University Of Tokyo
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Kurokawa T
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Miura Kazuhisa
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Murate Takashi
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Koshikawa Takashi
Department Of Pathology And Clinical Laboratories
-
Tachi Hiroshi
Department Of Brewing Junior College Of Tokyo University Of Agriculture
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Uehira Kazutaka
First Department Of Internal Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Tashiro Kazuhiro
Department Of Pathology Toyota Memorial Hospital
-
Suzuki Ritsuro
Department Of Hematopoietic Stem Cell Transplantation Data Management School Of Medicine Nagoya Univ
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Nakamura Shigeo
Department Of Cardiovascular Diseases. Kokura National Hospital
-
TACHI Hiroshi
Department of Brewing and Fermentation, Junior College of Tokyo University of Agriculture
-
NAKAMURA Shigeo
Department of Applied Chemistry, Faculty of Engineering, Kanagawa University
関連論文
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- Current treatment strategy and new agents in mantle cell lymphoma
- Inhibitory Effect of AL-3264, a New Antiallergic Agent, on the Prausnitz-Kustner Reaction and Leukotriene Production in Monkeys
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- A descriptive study evaluating the circumstances of medical treatment for acute pancreatitis before publication of the new JPN guidelines based on the Japanese administrative database associated with the Diagnosis Procedure Combination system